Skip to main content
. 2004 Jul 19;2004(3):CD001720. doi: 10.1002/14651858.CD001720.pub2

Dencker 1978.

Methods Allocation: randomised. 
 Blindness: double. 
 Duration: 3 years.
Participants Diagnosis: schizophrenia. 
 History: not reported. 
 N=36. 
 Age: mean 41 years. 
 Sex: 29M, 7F. 
 Setting: hospitalised (1 year), community (2 years).
Interventions 1. Pipothiazine palmitate: dose mean 152.3 mg/IM/month. N=33. 
 2. Fluphenazine decanoate: dose mean 27.8 mg/IM/month. N=34.
Outcomes Leaving the study early. 
 Additional medication.
Unable to use ‐ 
 Mental state: BPRS (no data). 
 Adverse effects: HRSD, EPS (no data). 
 Work capacity: ADL (data not usable).
Notes 63% attrition is reported in the treatment group. 
 Only data used is leaving the study early.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment? Unclear risk B ‐ Unclear